Cited by 648BRCA gene mutations in cancerDNA Repair MechanismsPARP inhibition in cancer therapy

The DOI matches its Crossref record; 92 of the 93 references it cites were found in a registry or an index.

BRCA1 and BRCA2 and the genetics of breast and ovarian cancer

Welcsh, P. L.·2001·Human Molecular Genetics

Open this paper in CoChat — free account

Abstract

Germline mutations in the tumor suppressor genes BRCA1 and BRCA2 predispose individuals to breast and ovarian cancers. Progress in determining the function of BRCA1 and BRCA2 suggests that they are involved in two fundamental cellular processes: DNA damage repair and transcriptional regulation. We evaluate current knowledge of BRCA1 and BRCA2 functions to explain why mutations in BRCA1 and BRCA2 lead specifically to breast and ovarian cancer. The BRCA1 and BRCA2 genes contain unusually high densities of repetitive elements. These features of the BRCAs genomic regions contribute to chromosomal instability of these genes. We propose that somatic alterations of BRCA1 and BRCA2 are common and driven by rearrangements between repetitive elements. Inherited and somatic mutations occur in BRCA1 and BRCA2; virtually all somatic mutations are the result of large genomic rearrangements. What are the consequences of such large somatic mutations of BRCA1 and BRCA2 in women with or without inherited mutations? The breast and ovary are estrogen-responsive tissues. Beginning in puberty, the breast epithelium proliferates rapidly in response to fluctuating levels of estrogen. We present a genetic model outlining how BRCA-deficient cells may gain uncontrolled proliferation leading to tumor formation. Central to this model of BRCA-mediated tumorigenesis are estrogen-mediated proliferation of breast and ovarian epithelium and the distinctive genomic context of the BRCA genes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/hmg/10.7.705

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J., Lee, M. K., Newman, B. M., Morrow, J. E., Anderson, L. A., Huey, B., & King, M. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,544
A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage
Paull, T. T., Rogakou, E. P., Yamazaki, V., Kirchgessner, C. U., Gellert, M., & Bonner, W. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00610-2 · Cited by 2,098
Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13
Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K. N., Seal, S., Tran, T. D., Averill, D., et al. (1994) · Science · doi:10.1126/science.8091231 · Cited by 1,918
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Cancer risks in BRCA2 mutation carriers.
Olsson, H. (1999) · Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,404
BRCA1 mutations in primary breast and ovarian carcinomas.
Futreal, P., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L., Haugen-Strano, A., Swensen, J., & Miki, Y. (1994) · Science · doi:10.1126/science.7939630 · Cited by 1,378
BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221

Flagged first, then by citations

Show all 93 references

1 of the 93 references couldn’t be matched to a known paper.

Sorted by citations

Items 401–500 of 647

Differential effects of cisplatin on cybrid cells with varying mitochondrial DNA haplogroups
Abedi, S., Yung, G., Atilano, S. R., Thaker, K., Chang, S., Chwa, M., Schneider, K., Udar, N., Bota, D. A., & Kenney, M. C. (2020) · PeerJ · doi:10.7717/peerj.9908 · Cited by 9
Relationship of Breast Cancer with Ovarian Cancer
Çelik, A., Acar, M., Moroski-Erkul, C. A., Gündüz, E., & Gündüz, M. (2015) · InTech eBooks · doi:10.5772/59682 · Cited by 9
Genome instability in blood cells of a BRCA1 + breast cancer family
Xiao, F., Kim, Y. C., Snyder, C., Wen, H., Chen, P. X., Luo, J., Becirovic, D., Downs, B. M., Cowan, K. H., Lynch, H. T., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-342 · Cited by 11
Differential Association of Cytochrome P450 3A4 Genotypes with Onsets of Breast Tumors in African American versus Caucasian Patients
McDaniel, D. O., Thurber, T., Lewis-Traylor, A., Berry, C., Barber, W. H., Zhou, X., Bigler, S. A., & Vance, R. B. (2011) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3182277e3b · Cited by 9
Complex Medical Decision-Making for a Trans-Feminine Youth with a BRCA1 Mutation
Wolf-Gould, C. S., Riley, M. R., & Carswell, J. M. (2018) · LGBT Health · doi:10.1089/lgbt.2017.0149 · Cited by 9
Mutational analysis of theBRCA1 gene in 30 Czech ovarian cancer patients
Zikán, M., Pohlreich, P., & Stříbrná, J. (2005) · Journal of Genetics · doi:10.1007/bf02715891 · Cited by 9
Human Genomics and Microarrays: Implications for the Plastic Surgeon
Cole, J., & Isik, F. F. (2002) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-200209010-00021 · Cited by 9
Proteogenomic characterization of invasive breast tumors in young women
Raj-Kumar, P.-K., Liu, J., Soltis, A. R., Bateman, N. W., Chen, Q., Sturtz, L. A., Deyarmin, B., Pierobon, M., Abulez, T. S., Praveen-Kumar, A., et al. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00793-0 · Cited by 13
Long-term risk of second malignancies in women after breast conservation therapy for ductal carcinoma in situ or early-stage breast cancer
Kushner, C. J., Hwang, W., Wang, S., Solin, L. J., & Vapiwala, N. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4729-7 · Cited by 9
Ovarian solid tumors: Current treatment and recent developments using stimuli-responsive polymers: A systemic review
Santhosh, S., Nanjan, M. J., & Chandrasekar, M. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.03.018 · Cited by 8
Accumulation of neoplastic traits prior to spontaneous in vitro transformation of rat cholangiocytes determines susceptibility to activated ErbB-2/Neu
Rozich, R. A., Mills, D. R., Brilliant, K. E., Callanan, H. M., Yang, D., Tantravahi, U., & Hixson, D. C. (2010) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2010.07.005 · Cited by 8
Networks and games for precision medicine
Biane, C., Delaplace, F., & Klaudel, H. (2016) · Biosystems · doi:10.1016/j.biosystems.2016.08.006 · Cited by 9
Tumor Suppressor Genes
Lü, Z., & Bast, R. C. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-98094-2_5 · Cited by 8
RPA, RFWD3 and BRCA2 at stalled forks: a balancing act
Duan, H., & Pathania, S. (2020) · Molecular & Cellular Oncology · doi:10.1080/23723556.2020.1801089 · Cited by 8
Next-Generation Sequencing in Order to Better Characterize a BRCA Variant of Uncertain Significance
Sorscher, S. M., & Ramkissoon, S. H. (2017) · Case Reports in Oncology · doi:10.1159/000478005 · Cited by 7
BRCA1 and BRCA2 associated breast cancer and the roles of current modelling systems in drug discovery
Trusler, O., Goodwin, J., & Laslett, A. L. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188459 · Cited by 8
Constitutional BRCA1 and MGMT Methylation Are Significant Risk Factors for Triple-Negative Breast Cancer and High-Grade Serous Ovarian Cancer in Saudi Women
Al‐Moghrabi, N., Al‐Showimi, M., Alqahtani, A., Almalik, O., Alhusaini, H., Almalki, G., Saad, A., & Alsunayi, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063108 · Cited by 7
Ovarian Cancer Prevention
Coe, K., López, A. M., & Hess, L. M. (2005) · Springer eBooks · doi:10.1007/3-540-26337-3_15 · Cited by 7
A kinetoplastid BRCA2 interacts with DNA replication protein CDC45
Oyola, S. O., Bringaud, F., & Melville, S. E. (2008) · International Journal for Parasitology · doi:10.1016/j.ijpara.2008.07.002 · Cited by 7
Lack of Correlation between Aberrant p16, RAR-β2, TIMP3, ERCC1, and BRCA1 Protein Expression and Promoter Methylation in Squamous Cell Carcinoma Accompanying Candida albicans-Induced Inflammation
Terayama, Y., Matsuura, T., & Ozaki, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159090 · Cited by 7
Breast Cancer: Epidemiology, Types, Diagnosis, and Treatment
Roy, M., Biswas, J., & Datta, A. (2023) · Springer eBooks · doi:10.1007/978-981-19-9925-3_1 · Cited by 7
Contraception as chemoprevention of ovarian cancer in BRCA1 and BRCA2 women
Loizzi, V., Cerbone, M., Arezzo, F., Silvestris, E., Damiani, G. R., Cazzato, G., Cicinelli, E., & Cormio, G. (2023) · HORMONES · doi:10.1007/s42000-023-00519-6 · Cited by 7
Genomic structure of chromosome 17 deletions in BRCA1-associated ovarian cancers
Chisholm, K. M., Goff, B. A., Garcia, R. L., King, M., & Swisher, E. M. (2008) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2008.02.004 · Cited by 7
Determinación de una mutación en el gen BRCA1 en una familia que presenta cáncer de mama hereditario
Marcela Gallardo, C., Faúndez, P., Cruz, A., Rodríguez, M., Manuel Álvarez, Z., & Pilar Carvallo de, S. Q. (2004) · Revista médica de Chile · doi:10.4067/s0034-98872004000200010 · Cited by 7
Using human genetics to discover new therapeutic targets for plasma lipids
Cohen, J. C. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12521 · Cited by 7
Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk‐associated and related genes
Guacci, A., Cordella, A., Rocco, T., Giurato, G., Nassa, G., Rizzo, F. M., Carlomagno, C., Pepe, S., Tarallo, R., & Weisz, A. (2018) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22418 · Cited by 7
A novel BRCA1 germline mutation promotes triple-negative breast cancer cells progression and enhances sensitivity to DNA damage agents
Xu, K., Shi, Y., Wang, X., Chen, Y., Tang, L., & Guan, X. (2019) · Cancer Genetics · doi:10.1016/j.cancergen.2019.08.004 · Cited by 7
Chemoresistance in uterine cancer: Mechanisms of resistance and current therapies
Arain, A., Muhsen, I. N., Abudayyeh, A., & Abdelrahim, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824299-5.00013-7 · Cited by 7
Genetic instability in the RAD51 and BRCA1 regions in breast cancer
Nowacka‐Zawisza, M., Bryś, M., Romanowicz‐Makowska, H., Kulig, A., & Krajewska, W. M. (2006) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-006-0063-x · Cited by 7
BRCA1 in initiation, invasion, and metastasis of breast cancer: a perspective from the tumor microenvironment
McCullough, S. D., Hu, Y., & Li, R. (2007) · Cancer metastasis · doi:10.1007/978-1-4020-5867-7_3 · Cited by 7
Hereditary Ovarian Cancer: Biology, Response to Chemotherapy and Prognosis
Safra, T. (2009) · Women s Health · doi:10.2217/whe.09.40 · Cited by 7
Mutation and expression analysis of LZTS1 in ovarian cancer
Arnold, J. M., Choong, D. Y. H., Lai, J., Campbell, I., & Chenevix‐Trench, G. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.03.008 · Cited by 6
Evolutionary dynamics of BRCA1 alterations in breast tumorigenesis
Roditi, L. D. V., & Franziska Michor, A. (2010) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2010.12.033 · Cited by 6
Breast tissue density change after oophorectomy in BRCA mutation carrier patients using visual and volumetric analysis
Lecler, A., Dunant, A., Delaloge, S., Wehrer, D., Moussa, T., Caron, O., & Balleyguier, C. (2017) · British Journal of Radiology · doi:10.1259/bjr.20170163 · Cited by 6
RESPONSE: Re: Dominant Negative ATM Mutations in Breast Cancer Families
Chenevix‐Trench, G. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.12.952 · Cited by 6
The clinical impact of the Human Genome Project: inherited variants in cancer care
Hopkinson, I., & Mackay, J. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf646 · Cited by 6
Radiotherapy and breast cancer: finally, an lncRNA perspective on radiosensitivity and radioresistance
Yazarlou, F., Martínez, I., & Lipovich, L. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1437542 · Cited by 5
Imaging and Screening of Hereditary Cancer Syndromes
Katabathina, V. S., Menias, C. O., & Prasad, S. R. (2017) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2017.06.011 · Cited by 5
Cancer diagnosis by biosensor-based devices: types and challenges
Manna, K., Mukherjee, N., Chatterjee, N., & Saha, K. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823424-2.00017-x · Cited by 5
Genetic instability-related lncRNAs predict prognosis and influence the immune microenvironment in breast cancer
Lv, Z., Wang, Q., Liu, X., Du, Z., Liang, W., Liu, T., Zheng, Y., Ma, B., & Xue, D. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.926984 · Cited by 5
The Clinical Significance of Genetic Variation in Ovarian Cancer
Ban, D., Housley, S. N., & McDonald, J. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310823 · Cited by 5
The Spectrum of Germline Nucleotide Variants in Gastric Cancer Patients in the Kyrgyz Republic
Bilyalov, A. I., Nikolaev, S., Михайловна, Д. А., Khatkov, I. E., Makhmudov, K., Isakova, J. T., Бакиров, Н. Д., Омурбаев, Э. Э., Osipova, A., Ramaldanov, R., et al. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080403 · Cited by 5
GTB – an online genome tolerance browser
Shihab, H. A., Rogers, M. F., Ferlaino, M., Campbell, C., & Gaunt, T. R. (2017) · BMC Bioinformatics · doi:10.1186/s12859-016-1436-4 · Cited by 5
BRCA1/2 Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients
Liontos, M., Zografos, E., Zoumpourlis, P., Andrikopoulou, Α., Svarna, A., Fiste, O., Kunadis, E., Papatheodoridi, A. M., Kaparelou, M., Koutsoukos, K., et al. (2021) · Current Oncology · doi:10.3390/curroncol28060377 · Cited by 6
Human alcoholism studies of genes identified through mouse quantitative trait locus analysis
Ehringer, M. A., Thompson, J., Conroy‐Ben, O., Goldman, D. A., Smith, T. L., Schuckit, M. A., & Sikela, J. M. (2002) · Addiction Biology · doi:10.1080/1355621021000005496 · Cited by 5
A case of contralateral breast cancer and skin cancer associated with NBN heterozygous pathogenic variant c.698_701delAACA
Gass, J. M., Jackson, J. L., Macklin, S., Blackburn, P., Hines, S. L., & Atwal, P. S. (2017) · Familial Cancer · doi:10.1007/s10689-017-9982-0 · Cited by 5
Prediction of novel miRNA biomarker candidates for diagnostic and prognostic analysis of STAD and LIHC: An integrated in silico approach
Kar, K., Fariha, A., Hossain, M. S., Tonmoy, M. I. Q., Hami, I., Roy, A. S., Shakil, S. K., Reza, H. A., Bahadur, N. M., & Rahaman, M. M. (2021) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2021.100581 · Cited by 5
Germline mutations of BRCA1 in two Korean hereditary breast/ovarian cancer families
Kim, T., Lee, K.-M., Choi, C. H., Lee, J., Lee, J., Bae, D., & Kim, B. (2006) · Oncology Reports · doi:10.3892/or.15.3.565 · Cited by 5
Screening for genomic rearrangements at BRCA1 locus in Iranian women with breast cancer using multiplex ligation-dependent probe amplification
Yassaee, V. R., Emamalizadeh, B., & Omrani, M. D. (2013) · Journal of Genetics · doi:10.1007/s12041-013-0223-5 · Cited by 5
Breast Cancer and the Environment
Institute of Medicine (2012) · National Academies Press eBooks · doi:10.17226/13263 · Cited by 5
Novel complex genomic rearrangement of the BRCA1 gene
Zikán, M., Pohlreich, P., Stribrna, J., Kleibl, Z., & Cibula, D. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2007.08.002 · Cited by 5
Modelling and calculation of dna damage and repair in mammalian cells induced by ionizing radiation of different quality
Taleei, R. (2013) · Figshare · Cited by 5
Decoding Breast Cancer Metabolism: Hunting BRCA Mutations by Raman Spectroscopy
Kopec, M., Romanowska-Pietrasiak, B., & Abramczyk, H. (2022) · Photochem · doi:10.3390/photochem2030048 · Cited by 4
Development of Erythema Nodosum After Olaparib Treatment in a Patient With Recurrent Breast Cancer and BRCA2 Mutation: A Case Report
Saito, M., Fujii, K., Banno, H., Ito, Y., & Nakano, S. (2023) · Cureus · doi:10.7759/cureus.44864 · Cited by 6
An Update and Translational Perspective in Genetics and Genomics of Breast Cancer
Umadevi, K., Priyanka, L. G., Clementina, R., Rao, E. S., Sundeep, D., & Kumari, S. (2025) · Current Breast Cancer Reports · doi:10.1007/s12609-024-00567-w · Cited by 4
Breast cancer: Small molecules targeting apoptosis, a prospective approach to safe scientific success
Choene, M. S., Mthembu, N. N., Dlamini, Z., Mokgotho, M. P., Wachira, J., & Motadi, L. R. (2012) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2012.37104 · Cited by 4
Breast Cancer Gene, BRCA1 and BRCA2
Choi, D. H. (2003) · Journal of Breast Cancer · doi:10.4048/jkbcs.2003.6.2.45 · Cited by 4
Hereditary Breast and Ovarian Cancer
Lux, M. P., Bani, M. R., Fasching, P. A., & Beckmann, M. W. (2016) · Springer eBooks · doi:10.1007/978-1-59745-458-2_26 · Cited by 5
A novel somatic BRCA2 point mutation in a metastatic pancreatic cancer patient: a case report
Wang, D., Guan, R., Qing, T., Liu, S., Yu, M., & Li, X. (2021) · BMC Medical Genomics · doi:10.1186/s12920-020-00850-6 · Cited by 4
Genomic and Immune Approach in Platinum Refractory HPV-Negative Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: A Novel Combined Profile
Mezi, S., Pomati, G., Zizzari, I. G., Filippo, A. D., Cerbelli, B., Cirillo, A., Fiscon, G., Amirhassankhani, S., Valentini, V., VINCENTIIS, M. D., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10112732 · Cited by 4
The association between exposure to PM2.5 components from coal combustion and mortality in female breast cancer patients
Su, M., Sun, H., Qiao, L., Lin, H. L., Zhang, Y., Qi, M., Yan, Y., Kang, W., Xu, L., Liu, G., et al. (2023) · Environmental Research Letters · doi:10.1088/1748-9326/acf590 · Cited by 4
Clinical factors used to support prophylactic mastectomy for a male BRCA2 mutation carrier
Guiahi, M., Gabram, S. G. A., Albain, K. S., Camacho, P. M., Krishnamachari, B., & Rajan, P. B. (2006) · Surgery · doi:10.1016/j.surg.2005.10.020 · Cited by 4
Genes de susceptibilidad al cáncer de mama
Dı́ez, O., Gutiérrez‐Enríquez, S., & y Cajal, T. R. (2006) · Medicina Clínica · doi:10.1157/13085493 · Cited by 6
Identification of novel intronic BRCA1 variants of uncertain significance in a Thai hereditary breast cancer family
Ratanaphan, A., Panomwan, P., Canyuk, B., & Maipang, T. (2011) · Journal of Genetics · doi:10.1007/s12041-011-0069-7 · Cited by 4
Hereditary Breast and Ovarian Cancer Genes
Scully, R., & Puget, N. (2003) · Humana Press eBooks · doi:10.1385/1-59259-328-3:041 · Cited by 4
Genomic-Glycosylation Aberrations in Tumor Initiation, Progression and Management
Ip, C. K. M., Yin, J., Ng, P. K., Lin, S., & Mills, G. B. (2016) · AIMS Medical Science · doi:10.3934/medsci.2016.4.386 · Cited by 5
Chemosensitivity of BRCA1-Mutated Ovarian Cancer Cells and Established Cytotoxic Agents
van Haaften, C., van Eendenburg, J., Boot, A., Corver, W. E., Haans, L. C. F., van Wezel, T., & Trimbos, J. B. (2017) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000001052 · Cited by 4
An optimizedBRCA1/2next-generation sequencing for different clinical sample types
Kim, Y., Cho, C., Ha, J., Kim, D., Kwon, S. Y., Oh, S. C., & Lee, K. (2019) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2020.31.e9 · Cited by 4
Re: Gene Expression Profiles of BRCA1-Linked, BRCA2-Linked, and Sporadic Ovarian Cancers
Bertucci, F., Eisinger, F., Tagett, R., Sobol, H., & Birnbaum, D. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1506 · Cited by 4
Loss of BRCA2 correlates with reduced long-term survival of sporadic breast cancer patients.
Hampl, J. A., Hampl, M., Reiss, G., Koch, R., Saeger, H., & Schackert, H. K. (2004) · PubMed · Cited by 4
CANCER BIOMARKERS
Getzenberg, R. H. (2019) · Cancer · doi:10.1002/9781119645214.ch6 · Cited by 4
Functional analysis of BRCA1 and BRCA2 splicing variants using a minigene assay
Yim, H., Youn, S., Chae, S. W., Kim, Y., Jang, J., Cho, S. I., Lee, J., & Seong, M. (2025) · Human Genomics · doi:10.1186/s40246-025-00853-3 · Cited by 3
Wnt Signaling Interactor WTIP (Wilms Tumor Interacting Protein) Underlies Novel Mechanism for Cardiac Hypertrophy
Jong, H. N. D., Dewey, F. E., Cordero, P., Victorio, R. A., Kirillova, A., Huang, Y., Madhvani, R. V., Seo, K., Werdich, A. A., Lan, F., et al. (2022) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.121.003563 · Cited by 3
Identification and management of familial breast cancer in Austria
Singer, C. F., Tan, Y. Y., & Rappaport, C. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0025 · Cited by 3
Venous thromboembolism incidence in cancer patients with germline BRCA mutations
Muñoz, A. J., de Toro, M., Ortega, L., López-Jiménez, C., Gutiérrez, A., Caamaño, D. S. J., Arregui, M., Lobato, N., Echavarría, I., Márquez‐Rodas, I., et al. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02678-7 · Cited by 3
BRCA1 and BRCA2 Mutations - Diagnostic and Therapeutic Implications
Valarmathi, M. T. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100842 · Cited by 2
A contribuição dos genes BRCA na predisposição hereditária ao câncer de mama BRCA Genes Contribution in the hereditary predisposition for breast cancer
Amendola, L. C., & Vieira, R. J. D. S. (2005) · Cited by 3
RECONSTRUCTIVE AND PLASTIC SURGERY FOR BREAST CANCER
Sobolevsky, V. A., Ivashkov, V. Y., & Mehtiyeva, N. I. G. (2017) · Practical oncology · doi:10.31917/1803246 · Cited by 3
Undergraduate Nursing Students' Perceived Knowledge and Attitudes Toward Genetics and Nursing Competencies for Genetics
Choi, H. (2014) · Journal of Korean Biological Nursing Science · doi:10.7586/jkbns.2014.16.2.69 · Cited by 3
Genetic Markers for Ovarian Cancer Risk: Are we Close to Seeing a Clinical Impact?
Moorman, P. G. (2012) · Personalized Medicine · doi:10.2217/pme.12.58 · Cited by 3
Regulation of the Angiogenesis Inhibitor Thrombospondin-1 by the Breast Cancer Susceptibility Gene-1 (BRCA1)
Grillo, J., DelloRusso, C., Lynch, R. C., Folkman, J., & Zaslavsky, A. (2011) · The Breast Journal · doi:10.1111/j.1524-4741.2011.01109.x · Cited by 3
Starting a Cancer Genetics Clinic in a County Hospital
Pirzadeh-Miller, S. M. (2009) · Oncology Issues · doi:10.1080/10463356.2009.11883469 · Cited by 3
Multi-Dimensional Scaling Analysis of Key Regulatory Genes in Prostate Cancer Using the TCGA Database
Boldrini, L., Faviana, P., Galli, L., Paolieri, F., Erba, P. A., & Bardi, M. (2021) · Genes · doi:10.3390/genes12091350 · Cited by 3
Ovarian Cancer Prevention
Chambers, S. K., & Hess, L. M. (2013) · Springer eBooks · doi:10.1007/978-3-642-38983-2_18 · Cited by 3
Synaptic and Recombination Nodules in Mammals: Structural Continuity with Shifting Protein Composition
Ashley, T. (2007) · Springer eBooks · doi:10.1007/7050_2007_035 · Cited by 3
How to Personalize Chemotherapy in Stage IV NSCLC?
Karachaliou, N., Rosell, R., & Carcereny, E. (2014) · Springer eBooks · doi:10.1007/978-3-319-06062-0_8 · Cited by 3
Inherited mutations impair responses to environmental carcinogens: Cancer prevention in mutation carriersPreprint
Friedenson, B. (2011) · Nature Precedings · doi:10.1038/npre.2011.6024.1 · Cited by 3
Clinical applications of Genome Polymorphism Scans.
Weber, J. L. (2006) · Biology Direct · doi:10.1186/1745-6150-1-16 · Cited by 3
Family history and risk assessment in black South African women with breast cancer
Wainstein, T. (2012) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 3
Penalized EM algorithm and copula skeptic graphical models for inferring networks for mixed variablesPreprint
Abegaz, F., & Wit, E. C. (2014) · arXiv (Cornell University) · doi:10.48550/arxiv.1401.5264 · Cited by 3
Frequencies of Single-Nucleotide Polymorphisms and Mutations in the BRCA1 Gene in Patients with Hereditary Breast or Ovarian Cancer
Karpukhin, A. V., Поспехова, Н. И., Lyubchenko, L. N., Loginova, A. N., Khomich, E. V., Budilov, A. V., Сергеев, А. С., Zakhar'ev, V. M., Гарькавцева, Р. Ф., & Ek, G. (2002) · Doklady Biological Sciences · doi:10.1023/a:1015346009037 · Cited by 3
Novel Cyanopyrimidine Derivatives as Potential Anticancer Agents
El-Hameed, R. H. A., Aly, O., Mohamed, M. E. S., Gharib, A. F., Mohamed, M. S., Ali, A., Khoder, Z. M., Taha, H., & Fatahala, S. S. (2025) · Molecules · doi:10.3390/molecules30071453 · Cited by 2
BRCA1 novel variation V1736D and in silico analysis of SNP Q356R in Sudanese patients with breast cancer
Aabdein, M. E. M. M., Elimam, A. A. M., Altayb, H. N., Eldeen, M. E.-F. M., Gasemelseed, M. M., FadlAlla, A. A., Osman, M. M., Osman, S. A., Saeed, H. A., Ali, M. S., et al. (2018) · F1000Research · doi:10.12688/f1000research.11395.4 · Cited by 2
Epithelial Ovarian Cancer Prevention
Chambers, S. K., & Hess, L. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-15935-1_20 · Cited by 1
The role of rRNA in maintaining genome stability
Li, P., & Yu, X. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103692 · Cited by 3
Pre-pubertal obesity compromises ovarian oxidative stress, DNA repair and chemical biotransformation
Timme, K., González-Alvarez, M. E., & Keating, A. F. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.116981 · Cited by 2
DNA damage and repair in patients undergoing myocardial perfusion single-photon emission computed tomography
Lorenzo, A. D., Fernandes, M. C. D. S., Romeiro, F., Botelho, A. P. A., & Dias, G. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-63537-3 · Cited by 2
Pathogenic variants in human DNA damage repair genes mostly arose after the latest human out-of-Africa migration
He, J., Kou, S. H., Li, J., Ding, X., & Wang, S. M. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1408952 · Cited by 2
Risk Factors of Recurrence and Metastasis of Breast Cancer Sub-types Based on Magnetic Resonance Imaging Techniques
del Campo, V., & Malaina, I. (2024) · Lecture notes in computer science · doi:10.1007/978-3-031-64629-4_5 · Cited by 2
Precision Therapy of Pancreatic Cancer: From Bench to Bedside
Ciecielski, K. J., Berninger, A., & Algül, H. (2020) · Visceral Medicine · doi:10.1159/000509232 · Cited by 2

Authors: Welcsh, P. L.
Affiliations: University of Washington (US)
Corresponding author: Welcsh, P. L.
Venue: Human Molecular Genetics
Publisher: Oxford University Press (OUP)
Published: 2001-04-01
Volume: 10
Issue: 7
Pages: 705-713
ISSN: 0964-6906 (ISSN-L)
1460-2083
DOI: 10.1093/hmg/10.7.705
OpenAlex: W2124371549
Cited by: 648
References: 93
Citations by year: 2026: 11 · 2025: 16 · 2024: 25 · 2023: 19 · 2022: 19 · 2021: 26 · 2020: 27 · 2019: 33 · 2018: 30 · 2017: 36 · 2016: 34 · 2015: 31 · 2014: 29 · 2013: 25 · 2012: 17
FWCI: 4.10
Type: journal article
Language: en
Open access: closed
Locations: Human Molecular Genetics (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ca027632-22)
National Cancer Institute (CA27632)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
Keywords: BRCA1, BRCA2, hereditary breast cancer, hereditary ovarian cancer, germline mutations, somatic mutations, DNA repair, transcriptional regulation, repetitive elements, chromosomal instability, genome rearrangement, carcinogenesis, tumor suppressor
MeSH terms: Breast Neoplasms, Cell Division, Chromosomes, Estrogens, Female, Humans, Models, Biological, Mutation, Neoplasm Proteins, Ovarian Neoplasms, Repetitive Sequences, Nucleic Acid, Transcription Factors, Gene Deletion, Genes, BRCA1, Genetic Predisposition to Disease, BRCA2 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

BRCA1 and BRCA2 and the genetics of breast and ovarian cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks